MONDAY, May 11, 2026 — The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
Bizengri (zenocutuzumab-zbco) is the first drug approved for adults with…
Blog
Leave a Reply